Ghent University Academic Bibliography

Advanced

Synthesis, radiosynthesis and preliminary in vivo evaluation of [I-123](4-fluorophenyl) {1-[2-(2(2-iodophenyl)ethyl]piperidin-4-yl}methanone, a potential 5-HT2A-antagonist for SPECT brain imaging

PETER BLANCKAERT UGent, Marleen Vandecapelle, Ludovicus Staelens, Ingrid Burvenich, Rudi Dierckx UGent and Guido Slegers UGent (2004) JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. 47(9). p.591-598
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
journal title
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
J. Label. Compd. Radiopharm.
volume
47
issue
9
pages
591-598 pages
publisher
JOHN WILEY & SONS LTD
Web of Science type
Article
Web of Science id
000223551900006
JCR category
CHEMISTRY, MEDICINAL
JCR impact factor
1.048 (2004)
JCR rank
24/36 (2004)
JCR quartile
3 (2004)
ISSN
0362-4803
language
English
UGent publication?
yes
classification
A1
id
295249
handle
http://hdl.handle.net/1854/LU-295249
date created
2004-10-14 11:16:00
date last changed
2016-12-19 15:44:04
@article{295249,
  author       = {BLANCKAERT, PETER and Vandecapelle, Marleen and Staelens, Ludovicus and Burvenich, Ingrid and Dierckx, Rudi and Slegers, Guido},
  issn         = {0362-4803},
  journal      = {JOURNAL OF LABELLED COMPOUNDS \& RADIOPHARMACEUTICALS},
  language     = {eng},
  number       = {9},
  pages        = {591--598},
  publisher    = {JOHN WILEY \& SONS LTD},
  title        = {Synthesis, radiosynthesis and preliminary in vivo evaluation of [I-123](4-fluorophenyl) \{1-[2-(2(2-iodophenyl)ethyl]piperidin-4-yl\}methanone, a potential 5-HT2A-antagonist for SPECT brain imaging},
  volume       = {47},
  year         = {2004},
}

Chicago
Blanckaert, Peter, Marleen Vandecapelle, Ludovicus Staelens, Ingrid Burvenich, Rudi Dierckx, and Guido Slegers. 2004. “Synthesis, Radiosynthesis and Preliminary in Vivo Evaluation of [I-123](4-fluorophenyl) {1-[2-(2(2-iodophenyl)ethyl]piperidin-4-yl}methanone, a Potential 5-HT2A-antagonist for SPECT Brain Imaging.” Journal of Labelled Compounds & Radiopharmaceuticals 47 (9): 591–598.
APA
Blanckaert, P., Vandecapelle, M., Staelens, L., Burvenich, I., Dierckx, R., & Slegers, G. (2004). Synthesis, radiosynthesis and preliminary in vivo evaluation of [I-123](4-fluorophenyl) {1-[2-(2(2-iodophenyl)ethyl]piperidin-4-yl}methanone, a potential 5-HT2A-antagonist for SPECT brain imaging. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 47(9), 591–598.
Vancouver
1.
Blanckaert P, Vandecapelle M, Staelens L, Burvenich I, Dierckx R, Slegers G. Synthesis, radiosynthesis and preliminary in vivo evaluation of [I-123](4-fluorophenyl) {1-[2-(2(2-iodophenyl)ethyl]piperidin-4-yl}methanone, a potential 5-HT2A-antagonist for SPECT brain imaging. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. JOHN WILEY & SONS LTD; 2004;47(9):591–8.
MLA
Blanckaert, Peter, Marleen Vandecapelle, Ludovicus Staelens, et al. “Synthesis, Radiosynthesis and Preliminary in Vivo Evaluation of [I-123](4-fluorophenyl) {1-[2-(2(2-iodophenyl)ethyl]piperidin-4-yl}methanone, a Potential 5-HT2A-antagonist for SPECT Brain Imaging.” JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS 47.9 (2004): 591–598. Print.